Oaktree, Sagent Win Bankruptcy Auction for Some Athenex Assets

Bankrupt Athenex Inc. will sell its pharmaceutical division’s assets in deals valued at about $41 million to creditor Oaktree Capital Management and Sagent Pharmaceuticals.

Handling the deal through its affiliates, Oaktree will apply $20 million it’s due to acquire Athenex Pharmaceutical Division’s accounts receivable, deposits and refund claims, according to Athenex’s filing Thursday with the US Bankruptcy Court for the Southern District of Texas.

Injectable products maker Sagent won the bankruptcy auction for the rest of Athenex Pharmaceutical Division’s assets with a $14 million bid and a deal to assume at least $7 million in liabilities. The assets sold to ...